Unlocking Nature’s Pharmacy: Exploring Secondary Metabolites Through Genome Mining and Advanced Cultivation Strategies
Microbial Bioactives · 01.08.2024 · 7 (1) · 1-8
DOI: 10.25163/microbbioacts.7110657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Bioactives, online erschienen am 01.08.2024.
Abstract (Originalsprache)
Microorganisms represent an immense reservoir of chemically diverse secondary metabolites (SMs), which are indispensable for medicine, agriculture, and biotechnology. Traditional culture-based screening approaches, often referred to as "grind and find," have historically yielded the majority of clinically relevant antibiotics, antitumor agents, and immunosuppressants. However, these methods face substantial limitations, including the “great plate count anomaly,” high rediscovery rates, and the inability to access transcriptionally silent or cryptic biosynthetic gene clusters (BGCs). Recent advances in genome mining, metagenomics, and bioinformatics have transformed natural product discovery, enabling researchers to explore the largely uncultured “microbial dark matter.” Tools such as antiSMASH, ClusterFinder, and PRISM allow high-confidence identification and chemical prediction of BGCs from environmental DNA, while approaches like iChip cultivation, OSMAC strategies, and co-culture techniques facilitate activation of cryptic pathways. Marine and host-associated microbiomes have emerged as particularly rich sources of novel bioactive compounds, often yielding unique chemical scaffolds with potent antimicrobial or anticancer activity. This systematic review and meta-analysis synthesize data from contemporary studies on BGC detection, cultivation innovations, and metabolite characterization, highlighting the impact of integrative genomics-metabolomics pipelines on SM discovery. Quantitative analyses demonstrate that targeted genome-guided strategies yield compounds with higher bioactivity and lower rediscovery rates compared to traditional screening. By bridging genomic insights with functional metabolite assays, these approaches offer a roadmap for sustainable drug discovery and biotechnological innovation.
Zitieren
APA
(2024). Unlocking Nature’s Pharmacy: Exploring Secondary Metabolites Through Genome Mining and Advanced Cultivation Strategies. Microbial Bioactives, 7(1), 1-8. https://doi.org/10.25163/microbbioacts.7110657
Vancouver
Unlocking Nature’s Pharmacy: Exploring Secondary Metabolites Through Genome Mining and Advanced Cultivation Strategies. Microbial Bioactives. 2024;7(1):1-8. doi:10.25163/microbbioacts.7110657
BibTeX
@article{euvimed2024,
title = {Unlocking Nature’s Pharmacy: Exploring Secondary Metabolites Through Genome Mining and Advanced Cultivation Strategies},
journal = {Microbial Bioactives},
year = {2024},
volume = {7},
number = {1},
pages = {1--8},
doi = {10.25163/microbbioacts.7110657}
}
EUVIMED